×
Shandong Weigao Medical Polymer Price/Book Ratio 2012-2024 | SHWGF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Shandong Weigao Medical Polymer price/book ratio from 2012 to 2024. Price/book ratio can be defined as
View More
Shandong Weigao Medical Polymer Price/Book Ratio 2012-2024 | SHWGF
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Shandong Weigao Medical Polymer price/book ratio from 2012 to 2024. Price/book ratio can be defined as
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$205.7B
Stryker (SYK)
$140B
Boston Scientific (BSX)
$123.1B
Medtronic (MDT)
$115.5B
EssilorLuxottica (ESLOY)
$107.3B
Lonza Group Ag (LZAGY)
$45.5B
Haleon (HLN)
$44B
GE HealthCare Technologies (GEHC)
$39.7B
ResMed (RMD)
$35.9B
Terumo (TRUMY)
$28.3B
Koninklijke Philips (PHG)
$24.9B
Zimmer Biomet Holdings (ZBH)
$21.4B
Baxter (BAX)
$18.3B
Insulet (PODD)
$16.5B
Smith & Nephew SNATS (SNN)
$11B
Bio-Rad Laboratories (BIO)
$10.3B
BellRing Brands (BRBR)
$8.6B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$7.5B
ICU Medical (ICUI)
$4.2B
TG Therapeutics (TGTX)
$4.2B
Prestige Consumer Healthcare (PBH)
$3.7B
Haemonetics (HAE)
$3.7B
Envista Holdings (NVST)
$3.6B
Perrigo (PRGO)
$3.6B
Neogen (NEOG)
$3.1B
GN Store Nord (GNNDY)
$3B
QuidelOrtho (QDEL)
$2.6B
Agios Pharmaceuticals (AGIO)
$2.6B
Green Thumb Industries (GTBIF)
$2.2B